article thumbnail

Insurance Agency Valuation 101: Understanding the Essentials

Sica Fletcher

As one of the most active M&A firms in the insurance sector, we are frequently asked how insurance agency valuations work. This article discusses the fundamentals of insurance agency valuations, plus a few lesser-known factors that play into these processes before we give an overview of the insurance M&A market in 2024.

article thumbnail

Contingent Value Rights: Key Components & Trends

Deal Lawyers

Contingent Value Rights, or CVRs, are the public company analog of an earnout, and like earnouts are a tool for bridging valuation gaps between buyers and sellers.

Valuation 160
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Public SaaS Company Valuations and What They Mean for Private Companies

Software Equity Group

Our report provides context for private companies to better understand factors influencing their valuations and evaluate how they can position themselves within a changing marketplace. This post will examine the current state of public SaaS company valuations and what it means for private companies. What is the SEG Index?

article thumbnail

The Cooley Outlook for 2018 M&A

Cooley M&A

What’s on tap for 2018 M&A? A recap of 2017 trends and the Cooley outlook on this year’s dealmaking: Buying Innovation: Retention and Non-Competes. For both old-line companies and tech giants, innovation is the name of the game. Use of Earn-Outs in Life Sciences Deals.

M&A 52
article thumbnail

Cyber insurance startup Coalition acquires privacy assistant Jumbo

TechCrunch: M&A

In 2018, Jumbo raised a $3.5 Last year, Index Ventures also led a $17 million round in the company at a $77 million post-money valuation. In its most recent funding round , the company raised a $250 million Series F investment at a valuation of $5 billion. Coalition has raised hundreds of millions of dollars over the years.

Insurance 161
article thumbnail

Key Components and Trends of CVRs in Life Sciences Public M&A Deals

The Harvard Law School Forum

In recent months, the life sciences industry has seen the reemergence of contingent value rights, or CVRs, in public company acquisitions as a way to bridge a valuation gap between buyers and sellers. Executive Summary This study addresses CVRs, the public M&A analog to the earnout used in private deals, which can be price-driven (e.g.,

M&A 64
article thumbnail

Insurance Agency EBITDA Multiples: 2024 Report

Sica Fletcher

Starting in H2 2022, the insurance M&A market has seen a notably difficult 18-month period, afflicted with high interest rates, lowered deal volumes, and lowered valuations. If they do, then we can expect to see valuations and, by extent, EBITDA multiples for insurance agencies rise.